164 related articles for article (PubMed ID: 25010612)
1. Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney.
Si YN; Bao HG; Xu L; Wang XL; Shen Y; Wang JS; Yang XB
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1843-51. PubMed ID: 25010612
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.
Si Y; Bao H; Han L; Shi H; Zhang Y; Xu L; Liu C; Wang J; Yang X; Vohra A; Ma D
J Transl Med; 2013 Jun; 11():141. PubMed ID: 23759023
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine on renal ischemia-reperfusion injury in rats: assessment by means of NGAL and histology.
de Carvalho AL; Vital RB; Kakuda CM; Braz JR; Castiglia YM; Braz LG; Módolo MP; Ribeiro OR; Domingues MA; Módolo NS
Ren Fail; 2015 Apr; 37(3):526-30. PubMed ID: 25613736
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil gelatinase-associated lipocalin (NGAL) may play a protective role against rats ischemia/reperfusion renal injury via inhibiting tubular epithelial cell apoptosis.
An S; Zang X; Yuan W; Zhuge Y; Yu Q
Ren Fail; 2013; 35(1):143-9. PubMed ID: 23151253
[TBL] [Abstract][Full Text] [Related]
5. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?
Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O
Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287
[TBL] [Abstract][Full Text] [Related]
6. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
[TBL] [Abstract][Full Text] [Related]
8. NGAL attenuates renal ischemia/reperfusion injury through autophagy activation and apoptosis inhibition in rats.
Zhang YL; Qiao SK; Wang RY; Guo XN
Chem Biol Interact; 2018 Jun; 289():40-46. PubMed ID: 29704511
[TBL] [Abstract][Full Text] [Related]
9. Effects of apigenin pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway.
Liu Y; Wang L; Du Y; Chen Z; Guo J; Weng X; Wang X; Wang M; Chen D; Liu X
Biomed Pharmacother; 2017 Nov; 95():1799-1808. PubMed ID: 28962085
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α
Li J; Chen Q; He X; Alam A; Ning J; Yi B; Lu K; Gu J
J Transl Med; 2018 Mar; 16(1):78. PubMed ID: 29566706
[TBL] [Abstract][Full Text] [Related]
11. Acute hyperglycemia prevents dexmedetomidine-induced preconditioning against renal ischemia-reperfusion injury.
Wang H; Chen H; Wang L; Liu L; Wang M; Liu X
Acta Cir Bras; 2014 Dec; 29(12):812-8. PubMed ID: 25517495
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells.
Luo C; Yuan D; Yao W; Cai J; Zhou S; Zhang Y; Hei Z
Life Sci; 2015 Feb; 122():72-7. PubMed ID: 25529146
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway.
Liu H; Li J; Jiang L; He J; Zhang H; Wang K
Braz J Med Biol Res; 2022; 55():e12145. PubMed ID: 35858000
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-κB p65 signal pathway.
Li YW; Zhang Y; Zhang L; Li X; Yu JB; Zhang HT; Tan BB; Jiang LH; Wang YX; Liang Y; Zhang XS; Wang WS; Liu HG
Gene; 2014 May; 542(1):46-51. PubMed ID: 24630969
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion.
Ragab D; Abdallah DM; El-Abhar HS
PLoS One; 2014; 9(5):e95313. PubMed ID: 24816434
[TBL] [Abstract][Full Text] [Related]
17. The Role of Janus Kinase/Signal Transducer and Activator of Transcription Signalling on Preventing Intestinal Ischemia/Reperfusion Injury with Dexmedetomidine.
Zhang X; Zhou J; Hu Q; Liu Z; Chen Q; Wang W; Zhang H; Zhang Q; Huang Y
J Nanosci Nanotechnol; 2020 May; 20(5):3295-3302. PubMed ID: 31635678
[TBL] [Abstract][Full Text] [Related]
18. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats.
Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K
Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study.
Kocoglu H; Ozturk H; Ozturk H; Yilmaz F; Gulcu N
Ren Fail; 2009; 31(1):70-4. PubMed ID: 19142813
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of cannabinoid type 2 receptor activation on renal ischemia-reperfusion injury.
Çakır M; Tekin S; Doğanyiğit Z; Çakan P; Kaymak E
Mol Cell Biochem; 2019 Dec; 462(1-2):123-132. PubMed ID: 31446615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
